Compare EOLS & LMB Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Current Price
| Metric | EOLS | LMB |
|---|---|---|
| Founded | 2012 | 1901 |
| Country | United States | United States |
| Employees | N/A | 1400 |
| Industry | Biotechnology: Pharmaceutical Preparations | Engineering & Construction |
| Sector | Health Care | Consumer Discretionary |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 550.9M | 579.3M |
| IPO Year | 2018 | 2014 |
| Metric | EOLS | LMB |
|---|---|---|
| Price | $8.00 | $51.93 |
| Analyst Decision | Strong Buy | Strong Buy |
| Analyst Count | 5 | 3 |
| Target Price | $15.50 | ★ $116.67 |
| AVG Volume (30 Days) | ★ 912.2K | 412.2K |
| Earning Date | 05-04-2026 | 05-05-2026 |
| Dividend Yield | N/A | N/A |
| EPS Growth | 1.23 | ★ 25.68 |
| EPS | N/A | ★ 0.76 |
| Revenue | $297,176,000.00 | ★ $646,804,000.00 |
| Revenue This Year | $13.27 | $15.96 |
| Revenue Next Year | $17.62 | $5.90 |
| P/E Ratio | ★ N/A | $66.47 |
| Revenue Growth | 11.61 | ★ 24.68 |
| 52 Week Low | $3.86 | $40.74 |
| 52 Week High | $9.31 | $114.95 |
| Indicator | EOLS | LMB |
|---|---|---|
| Relative Strength Index (RSI) | 45.18 | 50.79 |
| Support Level | $5.78 | $40.74 |
| Resistance Level | $8.43 | $84.79 |
| Average True Range (ATR) | 0.36 | 2.15 |
| MACD | -0.21 | 1.69 |
| Stochastic Oscillator | 18.60 | 84.17 |
Evolus Inc is a performance beauty company offering medical aesthetic products in the cash-pay aesthetic market. The company's commercially available products represent two product categories within medical aesthetics: injectable neurotoxins and injectable hyaluronic acid (HA) gels. Its commercial products are: Jeuveau, a proprietary 900-kilodalton, purified botulinum toxin type A formulation indicated for the temporary improvement in the appearance of moderate to severe frown lines, in adults; and Evolysse, a collection of injectable HA gels that utilizes first-generation cold technology. The line includes several products, including mid face, nasolabial folds, lips, and eyes. Geographically, the company currently has operations in the United States, Canada, Europe, and Australia.
Limbach Holdings Inc is a building systems solutions firm that designs, delivers, and maintains mechanical (heating, ventilation, and air conditioning), electrical, plumbing, and controls (MEPC) systems. The Company partners with owners and operators of facilities across healthcare, industrial and manufacturing, data centers, life sciences, higher education, and cultural and entertainment markets. It operates through two segments: Owner Direct Relationships (ODR), which generates maximum revenue and includes owner direct projects, maintenance, and service on MEPC systems; and General Contractor Relationships (GCR), which manages new construction or renovation projects involving MEPC systems awarded by general contractors or construction managers.